Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Isis Pharmaceuticals Inc

+ Add to Watchlist

ISIS:US

67.7600 USD 0.5900 0.88%

As of 20:10:00 ET on 05/22/2015.

Company Profile for Isis Pharmaceuticals Inc (ISIS)

Isis Pharmaceuticals, Inc. discovers and develops novel human therapeutic compounds. The company currently has various compounds in clinical trials for a variety of diseases such as Crohn's disease, psoriasis, asthma, and cancer. Isis' broad medical chemistry and biology research programs support efforts in both antisense and small molecule drug delivery.

Contact Information

Isis Pharmaceuticals Inc

1896 Rutherford Road
Carlsbad, CA 92008-7326
United States
Phone: 1-760-931-9200
Fax: 1-760-603-2700

Key Executives for Isis Pharmaceuticals Inc (ISIS)

Stanley T Crooke "Stan"Chairman/President/CEO/FounderB Lynne ParshallCOO/Secretary
Sarah BoyceChief Business OfficerElizabeth L HougenSenior VP:Finance/CFO
Patrick R O'NeilSenior VP:Legal/Gen CounselC Frank BennettSenior VP:Antisense Research
Richard S GearySenior VP:DevelopmentBrett P MoniaSenior VP:Drug Discovery
D Wade WalkeVP:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil